These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34967456)

  • 1. Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.
    Fleischer V; Ciolac D; Gonzalez-Escamilla G; Grothe M; Strauss S; Molina Galindo LS; Radetz A; Salmen A; Lukas C; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kümpfel T; Zettl UK; Knop M; Tumani H; Wiendl H; Gold R; Bittner S; Zipp F; Groppa S; Muthuraman M;
    Ann Neurol; 2022 Feb; 91(2):192-202. PubMed ID: 34967456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosis.
    Simpson AC; Hu C; Mowry EM; Naismith RT; Fitzgerald KC; Nourbakhsh B
    Mult Scler; 2024 May; 30(6):738-746. PubMed ID: 38525561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
    Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E
    J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I; Makshakov G; Evdoshenko E
    AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep gray matter and fatigue in MS: a T1 relaxation time study.
    Niepel G; Tench ChR; Morgan PS; Evangelou N; Auer DP; Constantinescu CS
    J Neurol; 2006 Jul; 253(7):896-902. PubMed ID: 16525881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.
    Yarnykh VL; Krutenkova EP; Aitmagambetova G; Repovic P; Mayadev A; Qian P; Jung Henson LK; Gangadharan B; Bowen JD
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):618-625. PubMed ID: 29439122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R; Hurwitz S; Tauhid S; Bakshi R
    BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in multiple sclerosis: The role of thalamus.
    Capone F; Collorone S; Cortese R; Di Lazzaro V; Moccia M
    Mult Scler; 2020 Jan; 26(1):6-16. PubMed ID: 31138052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy of reward-related striatal structures in fatigued MS patients is independent of physical disability.
    Damasceno A; Damasceno BP; Cendes F
    Mult Scler; 2016 May; 22(6):822-9. PubMed ID: 26238465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis.
    Høgestøl EA; Nygaard GO; Alnæs D; Beyer MK; Westlye LT; Harbo HF
    PLoS One; 2019; 14(4):e0210375. PubMed ID: 30933977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage.
    Ziccardi S; Tamanti A; Ruggieri C; Guandalini M; Marastoni D; Camera V; Montibeller L; Mazziotti V; Rossi S; Calderone M; Pizzini FB; Montemezzi S; Magliozzi R; Calabrese M
    Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200301. PubMed ID: 39178066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review.
    Arm J; Ribbons K; Lechner-Scott J; Ramadan S
    J Neurol Sci; 2019 May; 400():52-71. PubMed ID: 30903860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B; Azevedo C; Nunan-Saah J; Maghzi AH; Spain R; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?
    Jakimovski D; Topolski M; Kimura K; Marr K; Gandhi S; Ramasamy DP; Bergsland N; Hagemeier J; Weinstock-Guttman B; Zivadinov R
    Clin Auton Res; 2019 Jun; 29(3):329-338. PubMed ID: 30120624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-efficacy therapy reduces subcortical grey matter volume loss in Japanese patients with relapse-onset multiple sclerosis: A 2-year cohort study.
    Yokote H; Miyazaki Y; Toru S; Nishida Y; Hattori T; Niino M; Sanjo N; Yokota T
    Mult Scler Relat Disord; 2022 Nov; 67():104077. PubMed ID: 35926261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the neural underpinnings of alexithymia in multiple sclerosis.
    Chalah MA; Kauv P; Palm U; Lefaucheur JP; Hodel J; Créange A; Ayache SS
    Neurosci Lett; 2020 Apr; 725():134894. PubMed ID: 32147502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.